ProAxsis is pleased to announce the appointment of Sarah Ganniclefft to the newly created role of Sales and Marketing Manager. Sarah joins the company from Becton Dickinson, where she served as National Sales Manager for the Molecular Diagnostics Division. Amongst a host of diagnostic sales and marketing experience, she has also previously spent four years in the Point of Care Division at Roche Diagnostics. Sarah has taken up her new position on April 18th 2016.
Dr David Ribeiro, CEO of ProAxsis, said: “Building the infrastructure of ProAxsis is a key target for the company in 2016, as we build up our portfolio of lab-based immunoassays and point-of-care tests to measure active proteases such as neutrophil elastase. The appointment of Sarah is an important first step, and we look forward to announcing further additions to the team in the near future.”
ProAxsis is part of the NetScientific group and is one of the group’s core portfolio companies. The company is also supported by QUBIS, the commercialisation arm of Queens University.
Related News
ProAxsis Limited (www.proaxsis.com) is delighted to announce that it has secured a second licensing agreement with the Queen’s …
The potential benefits of ProAxsis’ novel ProteaseTag® Active Proteinase 3 Immunoassay will be discussed at the Winter meeting …
ProAxsis Limited has been declared as the “Innovative Business of the Year” at the Business Eye First …
